Edward Visse

966 total citations
38 papers, 756 citations indexed

About

Edward Visse is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Edward Visse has authored 38 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 17 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Edward Visse's work include Immunotherapy and Immune Responses (15 papers), Glioma Diagnosis and Treatment (9 papers) and Chemokine receptors and signaling (7 papers). Edward Visse is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Glioma Diagnosis and Treatment (9 papers) and Chemokine receptors and signaling (7 papers). Edward Visse collaborates with scholars based in Sweden, Germany and Denmark. Edward Visse's co-authors include Peter Siesjö, Anna Darabi, Sara Fritzell, Bengt Widegren, Emma Sandén, Hans Sjögren, Wiaam Badn, Johan Bengzon, Gesine Paul and Karin Dannaeus and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Edward Visse

35 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Visse Sweden 16 305 269 247 242 90 38 756
Ilaria Tamagno United States 13 202 0.7× 142 0.5× 221 0.9× 235 1.0× 82 0.9× 18 633
Chung Kwon Kim South Korea 20 360 1.2× 348 1.3× 523 2.1× 584 2.4× 76 0.8× 39 1.3k
Sridhar Reddy Chirasani Germany 7 216 0.7× 203 0.8× 142 0.6× 212 0.9× 156 1.7× 7 593
Anna Gieryng Poland 9 402 1.3× 282 1.0× 162 0.7× 230 1.0× 282 3.1× 12 796
Qiqun Zeng China 9 151 0.5× 134 0.5× 301 1.2× 556 2.3× 68 0.8× 9 986
Jérôme Kroonen Belgium 13 120 0.4× 332 1.2× 131 0.5× 371 1.5× 45 0.5× 18 758
Susobhan Sarkar Canada 19 564 1.8× 429 1.6× 381 1.5× 409 1.7× 264 2.9× 29 1.3k
Monica Patanè Italy 11 171 0.6× 225 0.8× 310 1.3× 238 1.0× 31 0.3× 25 704
Kati Turkowski Germany 13 530 1.7× 211 0.8× 205 0.8× 303 1.3× 301 3.3× 17 922
Ryan Bash United States 13 129 0.4× 183 0.7× 126 0.5× 187 0.8× 43 0.5× 25 517

Countries citing papers authored by Edward Visse

Since Specialization
Citations

This map shows the geographic impact of Edward Visse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Visse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Visse more than expected).

Fields of papers citing papers by Edward Visse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Visse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Visse. The network helps show where Edward Visse may publish in the future.

Co-authorship network of co-authors of Edward Visse

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Visse. A scholar is included among the top collaborators of Edward Visse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Visse. Edward Visse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kopecký, Jan, Edward Visse, Myriam Cerezo-Magaña, et al.. (2026). Mitoxantrone alters CD24/Siglec-10 expression in malignant brain tumor models. Scientific Reports. 16(1). 3696–3696.
2.
3.
4.
Visse, Edward, et al.. (2023). Prolonged and intense neuroinflammation after severe traumatic brain injury assessed by cerebral microdialysis with 300 kDa membranes. Journal of Neuroimmunology. 377. 578020–578020. 5 indexed citations
5.
Marklund, Niklas, et al.. (2022). Low Morbidity and Mortality in Children with Severe Traumatic Brain Injury Treated According to the Lund Concept: A Population-Based Study. Journal of Neurotrauma. 40(7-8). 720–729. 2 indexed citations
6.
Kopecký, Jan, et al.. (2022). Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions. Scientific Reports. 12(1). 4609–4609. 5 indexed citations
7.
Visse, Edward, et al.. (2020). Antisecretory Factor May Reduce ICP in Severe TBI—A Case Series. Frontiers in Neurology. 11. 95–95. 6 indexed citations
8.
Sandén, Emma, Cecilia Dyberg, Cecilia Krona, et al.. (2015). Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas. Journal of Neuro-Oncology. 123(1). 1–13. 12 indexed citations
9.
10.
11.
Fritzell, Sara, et al.. (2013). Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion. Cancer Immunology Immunotherapy. 62(9). 1463–1474. 41 indexed citations
12.
Badn, Wiaam, et al.. (2012). Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors. Cancer Immunology Immunotherapy. 61(8). 1191–1199. 21 indexed citations
13.
Paul, Gesine, Ílknur Özen, Nicolaj S. Christophersen, et al.. (2012). The Adult Human Brain Harbors Multipotent Perivascular Mesenchymal Stem Cells. PLoS ONE. 7(4). e35577–e35577. 161 indexed citations
14.
Fritzell, Sara, Wiaam Badn, Shorena Janelidze, et al.. (2008). Cure of established GL261 mouse gliomas after combined immunotherapy with GM‐CSF and IFNγ is mediated by both CD8+ and CD4+ T‐cells. International Journal of Cancer. 124(3). 630–637. 22 indexed citations
15.
16.
Badn, Wiaam, Anna Darabi, Shorena Janelidze, et al.. (2007). Inhibition of Inducible Nitric Oxide Synthase Enhances Anti‐tumour Immune Responses in Rats Immunized with IFN‐γ‐Secreting Glioma Cells. Scandinavian Journal of Immunology. 65(3). 289–297. 20 indexed citations
17.
Salford, Leif, Peter Siesjö, Gunnar Skagerberg, et al.. (2005). Immunization with autologous glioma cells transfected with IFN-g gene significantly prolongs survival in GBM-patients older than 50 years. Lund University Publications (Lund University). 5 indexed citations
18.
Janelidze, Shorena, et al.. (2002). Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNγ-secreting rat glioma cells. Journal of Neuroimmunology. 123(1-2). 135–143. 15 indexed citations
19.
Visse, Edward, et al.. (2000). Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-γ-transfected glioma cells. Cancer Immunology Immunotherapy. 49(3). 142–151. 12 indexed citations
20.
Visse, Edward, Peter Siesjö, Bengt Widegren, & Hans Sjögren. (1999). Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-γ, interleukin-7, or B7-1-transfected tumor cells. Cancer Gene Therapy. 6(1). 37–44. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Tamagno Breakdown of academic impact, for papers by Chung Kwon Kim Breakdown of academic impact, for papers by Sridhar Reddy Chirasani Breakdown of academic impact, for papers by Anna Gieryng Breakdown of academic impact, for papers by Qiqun Zeng Breakdown of academic impact, for papers by Jérôme Kroonen Breakdown of academic impact, for papers by Susobhan Sarkar Breakdown of academic impact, for papers by Monica Patanè Breakdown of academic impact, for papers by Kati Turkowski Breakdown of academic impact, for papers by Ryan Bash
Rankless by CCL
2026